Search research articles
Contact Us
Filters
Showing results (71-80 of 266) with videos related to
Page
of 27
Sort By:
Movement Disorders Clinical Practice
|
April 18, 2023
The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease
Daniël H B Speelberg, Max J Hulshoff, Elaine Book, et al.
The Lancet. Neurology
|
July 8, 2019
Recent developments in drug-induced movement disorders: a mixed picture
Stewart A Factor, Pierre R Burkhard, Stanley Caroff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 30, 2020
The Impact of COVID-19 on Access to Parkinson's Disease Medication
Julia Ling-Yu Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Movement Disorders Clinical Practice
|
October 7, 2025
Prognostic Value of Parkinson's Disease Subtypes in the LABS-PD Cohort: Functional Ability, Quality of Life and Mortality
Deepa Dash, Shirley Eberly, David Oakes, et al.
JAMA Neurology
|
March 22, 2016
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease
Daniel Weintraub, Claire Chiang, Hyungjin Myra Kim, et al.
Frontiers in Neurology
|
February 18, 2021
Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis
Sneha Mantri, Briana Edison, Lamees Alzyoud, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease
Sean J Udow, Douglas E Hobson, Galit Kleiner, et al.
The European Journal of Neuroscience
|
December 1, 2022
Genetic variation in the dopamine system is associated with mixed-strategy decision-making in patients with Parkinson's disease
Ashley C Parr, Heidi C Riek, Brian C Coe, et al.
Movement Disorders Clinical Practice
|
January 4, 2025
Fox Insight: Most Bothersome Symptoms in Early-Stage Parkinson's Disease
Aaron Lerner, Jennifer R Mammen, Mirinda Tyo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 9, 2021
Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease
Priti Gros, Xuesong Wang, Jun Guan, et al.
Page
of 27
Search research articles
Search
Showing results (71-80 of 266) with videos related to
Sort By:
Page
of 27
Movement Disorders Clinical Practice
|
April 18, 2023
The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease
Daniël H B Speelberg, Max J Hulshoff, Elaine Book, et al.
The Lancet. Neurology
|
July 8, 2019
Recent developments in drug-induced movement disorders: a mixed picture
Stewart A Factor, Pierre R Burkhard, Stanley Caroff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 30, 2020
The Impact of COVID-19 on Access to Parkinson's Disease Medication
Julia Ling-Yu Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Movement Disorders Clinical Practice
|
October 7, 2025
Prognostic Value of Parkinson's Disease Subtypes in the LABS-PD Cohort: Functional Ability, Quality of Life and Mortality
Deepa Dash, Shirley Eberly, David Oakes, et al.
JAMA Neurology
|
March 22, 2016
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease
Daniel Weintraub, Claire Chiang, Hyungjin Myra Kim, et al.
Frontiers in Neurology
|
February 18, 2021
Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis
Sneha Mantri, Briana Edison, Lamees Alzyoud, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease
Sean J Udow, Douglas E Hobson, Galit Kleiner, et al.
The European Journal of Neuroscience
|
December 1, 2022
Genetic variation in the dopamine system is associated with mixed-strategy decision-making in patients with Parkinson's disease
Ashley C Parr, Heidi C Riek, Brian C Coe, et al.
Movement Disorders Clinical Practice
|
January 4, 2025
Fox Insight: Most Bothersome Symptoms in Early-Stage Parkinson's Disease
Aaron Lerner, Jennifer R Mammen, Mirinda Tyo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 9, 2021
Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease
Priti Gros, Xuesong Wang, Jun Guan, et al.
Page
of 27